NO20030127D0 - Indolderivater nyttige for behandling av CNS-forstyrrelser - Google Patents

Indolderivater nyttige for behandling av CNS-forstyrrelser

Info

Publication number: NO20030127D0
Authority: NO; Norway
Prior art keywords: treatment; cns disorders; indole derivatives; derivatives useful; useful
Prior art date: 2000-07-21

Application number

NO20030127A

Other languages

English (en)

Other versions

NO323799B1 (no

NO20030127L (no

Inventor

Jakob Felding

Benny Bang-Andersen

Garrick Paul Smith

Kim Andersen

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-21

Filing date

2003-01-10

Publication date

2003-01-10

2003-01-10 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

2003-01-10 Publication of NO20030127D0 publication Critical patent/NO20030127D0/no

2003-01-10 Publication of NO20030127L publication Critical patent/NO20030127L/no

2007-07-09 Publication of NO323799B1 publication Critical patent/NO323799B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Anesthesiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Indole Compounds (AREA)

NO20030127A 2000-07-21 2003-01-10 Indolderivater, farmasoytisk sammensetning inneholdende dem og deres anvendelse. NO323799B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DKPA200001123		2000-07-21
PCT/DK2001/000507 WO2002008223A1 (en)	2000-07-21	2001-07-17	Indole derivatives useful for the treatment of cns disorders

Publications (3)

Publication Number	Publication Date
NO20030127D0 true NO20030127D0 (no)	2003-01-10
NO20030127L NO20030127L (no)	2003-01-10
NO323799B1 NO323799B1 (no)	2007-07-09

Family

ID=8159625

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20030127A NO323799B1 (no)	2000-07-21	2003-01-10	Indolderivater, farmasoytisk sammensetning inneholdende dem og deres anvendelse.

Country Status (28)

Country	Link
US (1)	US6743809B2 (no)
EP (1)	EP1305307B1 (no)
JP (1)	JP2004504396A (no)
KR (1)	KR100851793B1 (no)
CN (1)	CN1264838C (no)
AR (1)	AR029858A1 (no)
AT (1)	ATE266024T1 (no)
AU (2)	AU8173801A (no)
BG (1)	BG107528A (no)
BR (1)	BR0112998A (no)
CA (1)	CA2416212C (no)
CZ (1)	CZ301114B6 (no)
DE (1)	DE60103162T2 (no)
EA (1)	EA004749B1 (no)
ES (1)	ES2219554T3 (no)
HR (1)	HRP20030015A2 (no)
HU (1)	HUP0302820A3 (no)
IL (2)	IL153605A0 (no)
IS (1)	IS2172B (no)
MX (1)	MXPA02012927A (no)
NO (1)	NO323799B1 (no)
NZ (1)	NZ523436A (no)
PT (1)	PT1305307E (no)
SK (1)	SK286701B6 (no)
TR (1)	TR200401488T4 (no)
UA (1)	UA73995C2 (no)
WO (1)	WO2002008223A1 (no)
ZA (1)	ZA200300287B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ547314A (en)	2003-11-17	2010-02-26	Boehringer Ingelheim Int	Novel piperidine-substituted indoles- or hetero-derivatives thereof and their use as modulators of chemokine receptor (CCR-3)
TWI391387B (zh) *	2004-05-12	2013-04-01	Eisai R&D Man Co Ltd	具有哌啶環之吲哚衍生物
ATE531706T1 (de)	2005-04-30	2011-11-15	Boehringer Ingelheim Int	Neue piperidin-substituierte indole und ihre verwendung als ccr-3-modulatoren
WO2008049874A1 (en)	2006-10-27	2008-05-02	Boehringer Ingelheim International Gmbh	Piperidyl-propane-thiol ccr3 modulators
CN101486654B (zh) *	2009-03-04	2012-10-10	西安近代化学研究所	2-甲基-3-硝基苯乙酸合成方法
CN110041318B (zh) *	2018-01-17	2022-07-29	中国科学院上海药物研究所	一类多巴胺d5受体激动剂及其制备和应用
CN110498789B (zh) *	2018-05-17	2022-04-05	上海医药工业研究院	芳烷哌啶类衍生物及其在多靶点抗抑郁症中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2322470A1 (de) *	1973-05-04	1974-11-21	Boehringer Sohn Ingelheim	Neue indolyl-piperidino-(bzw. 1,2,5,6tetrahydro-pyridyl-)butyrophenone und verfahren zu ihrer herstellung
AT332401B (de) *	1973-11-26	1976-09-27	Roussel Uclaf	Verfahren zur herstellung von neuen (4'-(3''-indolyl)-piperidino)-alkylarylketonderivaten
DE3882614T2 (de) *	1987-08-13	1993-11-18	Glaxo Group Ltd	Indol-Derivate.
GB8719167D0 (en) *	1987-08-13	1987-09-23	Glaxo Group Ltd	Chemical compounds
WO1994003444A1 (en) *	1992-08-05	1994-02-17	John Wyeth & Brother Limited	Amide derivatives
PL311204A1 (en) *	1993-04-22	1996-02-05	Pfizer Res & Dev	Indole derivatives as antagonists of 5-ht-like receptors for use in hemicrania
ES2063700B1 (es) *	1993-04-28	1995-07-16	Vita Invest Sa	Agente activo sobre el sistema nervioso central, proceso para su preparacion y composiciones farmaceuticas que lo contengan.
US5576321A (en) *	1995-01-17	1996-11-19	Eli Lilly And Company	Compounds having effects on serotonin-related systems
GB9718712D0 (en) *	1997-09-03	1997-11-12	Merck Sharp & Dohme	Theraputic Agents

2001
- 2001-07-17 HR HR20030015A patent/HRP20030015A2/hr not_active Application Discontinuation
- 2001-07-17 SK SK203-2003A patent/SK286701B6/sk not_active IP Right Cessation
- 2001-07-17 UA UA2003010167A patent/UA73995C2/uk unknown
- 2001-07-17 CA CA002416212A patent/CA2416212C/en not_active Expired - Fee Related
- 2001-07-17 AU AU8173801A patent/AU8173801A/xx active Pending
- 2001-07-17 MX MXPA02012927A patent/MXPA02012927A/es active IP Right Grant
- 2001-07-17 KR KR1020037000850A patent/KR100851793B1/ko not_active Expired - Fee Related
- 2001-07-17 HU HU0302820A patent/HUP0302820A3/hu unknown
- 2001-07-17 JP JP2002514129A patent/JP2004504396A/ja active Pending
- 2001-07-17 AU AU2001281738A patent/AU2001281738B2/en not_active Ceased
- 2001-07-17 EA EA200300179A patent/EA004749B1/ru not_active IP Right Cessation
- 2001-07-17 TR TR2004/01488T patent/TR200401488T4/xx unknown
- 2001-07-17 EP EP01960182A patent/EP1305307B1/en not_active Expired - Lifetime
- 2001-07-17 CN CNB018151078A patent/CN1264838C/zh not_active Expired - Fee Related
- 2001-07-17 CZ CZ20030196A patent/CZ301114B6/cs not_active IP Right Cessation
- 2001-07-17 IL IL15360501A patent/IL153605A0/xx unknown
- 2001-07-17 AT AT01960182T patent/ATE266024T1/de not_active IP Right Cessation
- 2001-07-17 NZ NZ523436A patent/NZ523436A/en unknown
- 2001-07-17 BR BR0112998-8A patent/BR0112998A/pt not_active IP Right Cessation
- 2001-07-17 WO PCT/DK2001/000507 patent/WO2002008223A1/en not_active Ceased
- 2001-07-17 PT PT01960182T patent/PT1305307E/pt unknown
- 2001-07-17 ES ES01960182T patent/ES2219554T3/es not_active Expired - Lifetime
- 2001-07-17 DE DE60103162T patent/DE60103162T2/de not_active Expired - Fee Related
- 2001-07-20 AR ARP010103457A patent/AR029858A1/es unknown
2002
- 2002-12-23 IS IS6663A patent/IS2172B/is unknown
- 2002-12-24 IL IL153605A patent/IL153605A/en not_active IP Right Cessation
2003
- 2003-01-10 NO NO20030127A patent/NO323799B1/no not_active IP Right Cessation
- 2003-01-10 ZA ZA200300287A patent/ZA200300287B/en unknown
- 2003-01-17 US US10/347,574 patent/US6743809B2/en not_active Expired - Fee Related
- 2003-02-05 BG BG107528A patent/BG107528A/bg unknown

Also Published As

Publication number	Publication date
SK286701B6 (sk)	2009-03-05
KR100851793B1 (ko)	2008-08-13
AR029858A1 (es)	2003-07-16
ZA200300287B (en)	2004-03-02
DE60103162D1 (de)	2004-06-09
SK2032003A3 (en)	2003-06-03
US6743809B2 (en)	2004-06-01
CA2416212A1 (en)	2002-01-31
ATE266024T1 (de)	2004-05-15
CN1451002A (zh)	2003-10-22
IS6663A (is)	2002-12-23
NO323799B1 (no)	2007-07-09
PT1305307E (pt)	2004-09-30
EA004749B1 (ru)	2004-08-26
EP1305307B1 (en)	2004-05-06
AU8173801A (en)	2002-02-05
NZ523436A (en)	2004-07-30
CA2416212C (en)	2007-10-30
US20030166664A1 (en)	2003-09-04
IS2172B (is)	2006-11-15
AU2001281738B2 (en)	2006-12-21
HRP20030015A2 (en)	2005-02-28
MXPA02012927A (es)	2003-05-15
EP1305307A1 (en)	2003-05-02
CZ301114B6 (cs)	2009-11-11
HK1059782A1 (en)	2004-07-16
IL153605A0 (en)	2003-07-06
UA73995C2 (en)	2005-10-17
EA200300179A1 (ru)	2003-06-26
KR20030017643A (ko)	2003-03-03
JP2004504396A (ja)	2004-02-12
CZ2003196A3 (cs)	2003-05-14
BR0112998A (pt)	2003-06-24
ES2219554T3 (es)	2004-12-01
NO20030127L (no)	2003-01-10
HUP0302820A2 (hu)	2003-12-29
TR200401488T4 (tr)	2004-08-23
BG107528A (bg)	2003-10-31
PL359157A1 (en)	2004-08-23
CN1264838C (zh)	2006-07-19
HUP0302820A3 (en)	2006-04-28
DE60103162T2 (de)	2005-05-04
WO2002008223A1 (en)	2002-01-31
IL153605A (en)	2008-07-08

Publication	Publication Date	Title
NO20026263L (no)	2002-12-27	Sulfonyl-pyrrolidin-derivater anvendelige for behandling av neurologiske forstyrrelser
NO20032801D0 (no)	2003-06-19	Tiazolderivater for behandling av PPAR relaterte forstyrrelser
NO20014047L (no)	2001-10-22	Monoamin reopptaksinhibitorer for behandling av CNS forstyrrelser
NO993051L (no)	1999-12-23	Intranasale formuleringer for behandling av seksuelle forstyrrelser
NO20041386L (no)	2004-05-11	Kombinasjoner for bahandling av immunoinflammatoriske forstyrrelser
DK1165510T3 (da)	2006-02-06	1-arensulfonyl-2-aryl-pyrrolidin- og -piperidinderivater til behandling af CNS-lidelser
NO20026005L (no)	2002-12-13	Indolderivater nyttige for behandlingen av CNS-forstyrrelser
HRP20030052A2 (en)	2005-02-28	4-, 5-, 6- and 7-indole derivatives useful for the treatment of cns disorders
NO20030127D0 (no)	2003-01-10	Indolderivater nyttige for behandling av CNS-forstyrrelser
NO20011892D0 (no)	2001-04-17	3-tetrahydropyridin-4-yl-indoler for behandling av psykotiske forstyrrelser
NO20026029D0 (no)	2002-12-16	Indolderivater nyttige for behandlingen av CNS-forstyrrelser
NO20026028D0 (no)	2002-12-16	Indolderivater nyttige for behandlingen av CNS-forstyrrelser
NO20030717D0 (no)	2003-02-14	Forbindelser for behandling av avhengighetsforstyrrelser
NO20012612D0 (no)	2001-05-28	Isonipecotamider for behandling av integren-formidlede lidelser
NO993948D0 (no)	1999-08-17	Anvendelse av aryl-cykloheksylamin-derivater mot CNS-forstyrrelser
IL153234A0 (en)	2003-07-06	Indole derivatives useful for the treatment of cns disorders
IL153351A0 (en)	2003-07-06	Indole derivatives useful for the treatment of cns disorders
SI1294710T1 (en)	2005-10-31	Indole derivatives useful for the treatment of cns disorders
SI1305307T1 (en)	2004-10-31	Indole derivatives useful for the treatment of cns disorders
SI1309586T1 (sl)	2006-06-30	Derivati 4-,5-,6- in 7-indola uporabni za zdravljenje motenj cns
NO20011189L (no)	2001-10-01	Innretning for behandling av suspensjoner

Legal Events

Date	Code	Title	Description
2010-03-01	MM1K	Lapsed by not paying the annual fees